ImmunityBio
IBRX
#2599
Rank
S$8.26 B
Marketcap
S$7.77
Share price
-8.37%
Change (1 day)
177.58%
Change (1 year)

Earnings for ImmunityBio (IBRX)

Earnings in 2026 (TTM): -S$1.13 Billion

According to ImmunityBio's latest financial reports the company's current earnings are S$0.16 Billion. In 2025 the company made an earning of -S$0.31 Billion, an increase over its 2024 earnings that were of -S$0.38 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ImmunityBio from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$1.13 Billion266.37%
2025 -S$0.31 Billion-16.85%
2024 -S$0.38 Billion-36.76%
2023 -S$0.59 Billion28.52%
2022 -S$0.46 Billion5.61%
2021 -S$0.44 Billion54.4%
2020 -S$0.28 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-S$0.21 Billion-82.22%๐Ÿ‡บ๐Ÿ‡ธ USA